Novalead Pharma Private Limited, a active private limited company, was established on 31 October 2007 in Pune, Maharashtra, India. Engaging in pharma contract r&d within the information and communication sector, it holds CIN: U73100PN2007PTC130929. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹3.74 Cr and a paid-up capital of ₹0.18 M.
It upholds a compliant status. Its leadership includes Sankara Narayanan Sankarasubramanian (Nominee Director), Sudhir Kulkarni Appaji (Director), Vandan Girdharlal Agrawal (Nominee Director). Past directors included Sankara Narayanan Sankarasubramanian, Homi Rustam Khusrokhan, Mohamed Iqbal Dharamsi. It holds no open charges and ₹3.34 Cr settled loans. Its latest AGM occurred on 24 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No-05, Third Floor, Ram Indu Park, Survey No-131/1B/2/11, Baner Taluka Have, Li,, Pune, Maharashtra, 411045.
U73100PN2007PTC130929
130929
31 October 2007
₹3.74 Cr
₹0.18 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Novalead Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sankara Narayanan Sankarasubramanian | Nominee Director | 24 Nov 2022 | Current |
| Sudhir Kulkarni Appaji | Director | 17 Aug 2009 | Current |
| Vandan Girdharlal Agrawal | Nominee Director | 24 Nov 2022 | Current |
| Atul Sharad Aslekar | Director | 31 Oct 2007 | Current |
| Supreet Deshpande Kiran | Director | 31 Oct 2007 | Current |
| Girish Vithalrao Lakhe | Director | 17 Aug 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Alternate Director | 23 Mar 2021 | Past |
| Pramod Abcsdd | Director | 15 Sep 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
| Pramod Abcsdd | Nominee Director | 29 Sep 2021 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2009 | Past |
| Pramod Abcsdd | Nominee Director | 25 Mar 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Novalead Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 513.86% increase. The company also saw a substantial improvement in profitability, with a 353.23% increase in profit. The company's net worth Soared by an impressive increase of 17.9%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Novalead Pharma had a promoter holding of 42.79% and a public holding of 57.21%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹33,380,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Jan 2011 | Biotechnology Industry Research Assistance Council | ₹3.34 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Novalead Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Novalead Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novalead Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Novalead Pharma Private Limited last Annual general meeting of members was held on 24 Sep 2024 as per latest MCA records. was completed.
Progress on Novalead Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was documented.
Progress on A charge registered on 03 Jan 2011 via Charge ID 10267794 with Biotechnology Industry Research Assistance Council was fully satisfied on 21 Mar 2024. was documented.
Progress on Sankara Narayanan Sankarasubramanian was appointed as a Nominee Director was appointed as a Nominee Director on 24 Nov 2022 & has been associated with this company since 3 years 5 days . was documented.
Progress on Vandan Girdharlal Agrawal was appointed as a Nominee Director was appointed as a Nominee Director on 24 Nov 2022 & has been associated with this company since 3 years 5 days . was documented.
The activity A charge with Biotechnology Industry Research Assistance Council of Rs. 3.34 Cr registered on 03 Jan 2011 with Charge ID 10267794 was modified on 23 Sep 2015. was completed.
The CIN of Novalead Pharma Private Limited is U73100PN2007PTC130929.
Novalead Pharma Private Limited is headquartered at Plot No-05, Third Floor, Ram Indu Park, Survey No-131/1B/2/11, Baner Taluka Have, Li,, Pune, Maharashtra, 411045.
Novalead Pharma Private Limited was incorporated on 31 October 2007.
The current directors of Novalead Pharma Private Limited are
The primary industry of Novalead Pharma Private Limited is Information And Communication.
Novalead Pharma Private Limited is unlisted.
The authorized capital of Novalead Pharma Private Limited is ₹3.74 Cr, and the paid-up capital is ₹0.18 M.
The compliance status of Novalead Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX